Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Liquidia Corporation

    Client Virtual Booth

    LIQUIDIA CORPORATION

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Liquidia Corporation
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    419 Davis Drive, Suite 100 Morrisville, NC 27560
    Telephone
    Telephone
    +1 919-328-4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://liquidia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/liquidia-technologies
    Twitter
    Twitter
    https://twitter.com/Liquidia_Inc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Liquidia wins against United Therapeutics in patent battle over PAH drug
    Liquidia wins against United Therapeutics in patent battle over PAH drug

    https://endpts.com/federal-judge-rules-fda-can-move-forward-with-potential-approval-of-liquidias-version-of-tyvaso/

    Katherine Lewin ENDPTS
    02 Apr 2024
    Share Share
    Courts clear FDA to approve Liquidia's PAH drug Yutrepia
    Courts clear FDA to approve Liquidia's PAH drug Yutrepia

    https://www.fiercepharma.com/pharma/fda-cleared-approve-liquidias-inhaled-pah-drug-rival-uniteds-tyvaso

    Kevin Dunleavy FIERCE PHARMA
    02 Apr 2024
    Share Share
    United Therapeutics starts litigation with FDA over rival Liquidia's drug application
    United Therapeutics starts litigation with FDA over rival Liquidia's drug application

    https://www.reuters.com/business/healthcare-pharmaceuticals/united-therapeutics-starts-litigation-with-fda-allowing-liquidias-drug-2024-02-21/

    REUTERS
    22 Feb 2024
    Share Share
    Liquidia and United Therapeutics could bring new lung indication into legal saga
    Liquidia and United Therapeutics could bring new lung indication into legal saga

    https://endpts.com/liquidia-and-united-therapeutics-could-bring-new-lung-indication-into-legal-saga/

    Katherine Lewin ENDPTS
    29 Jun 2023
    Share Share
    Liquidia Reports Full Year 2022 Financial Results and Provides Corporate Update
    Liquidia Reports Full Year 2022 Financial Results and Provides Corporate Update

    https://www.liquidia.com/news-releases/news-release-details/liquidia-corporation-reports-full-year-2022-financial-results

    PRESS RELEASE
    16 Mar 2023
    Share Share
    Liquidia to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
    Liquidia to Report Full Year 2022 Financial Results on Thursday, March 16, 2023

    https://www.liquidia.com/news-releases/news-release-details/liquidia-corporation-report-full-year-2022-financial-results

    PRESS RELEASE
    09 Mar 2023
    Share Share
    Liquidia Announces Collaboration to Develop a New Infusion Pump of Treprostinil
    Liquidia Announces Collaboration to Develop a New Infusion Pump of Treprostinil

    https://www.globenewswire.com/news-release/2022/12/05/2567822/0/en/Liquidia-Announces-Collaboration-to-Develop-a-New-Infusion-Pump-for-Subcutaneous-Delivery-of-Treprostinil-Injection-to-Treat-Pulmonary-Arterial-Hypertension-PAH.html

    GLOBENEWSWIRE
    05 Dec 2022
    Share Share
    The CEO & Director Of Liquidia Corporation Roger Jeffs, Has Just Spent US$244k Buying 2.6% More Shares
    The CEO & Director Of Liquidia Corporation Roger Jeffs, Has Just Spent US$244k Buying 2.6% More Shares

    https://uk.sports.yahoo.com/news/trade-alert-ceo-director-liquidia-122405590.html

    YAHOO
    10 Sep 2022
    Share Share
    Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8:00am E.T.
    Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8:00am E.T.

    https://www.liquidia.com/news-releases/news-release-details/liquidia-provides-update-hatch-waxman-litigation-and-host-call

    PRESS RELEASE
    31 Aug 2022
    Share Share
    Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    https://www.liquidia.com/news-releases/news-release-details/liquidia-corporation-reports-inducement-grants-under-nasdaq-3

    PRESS RELEASE
    22 Aug 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search